Stéphane Bancel, Moderna CEO (Steven Ferdman/Getty Images)
Covid-19 roundup: Moderna begins PhII/III vaccine study in adolescents; Pfizer and BioNTech's vaccine gets an OK in Canada as the FDA meets to discuss emergency use
Moderna has launched a Phase II/III study of its Covid-19 vaccine in adolescents younger than 18 and older than 12, with the goal of reading …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
